UiPath grants director 34,582 RSUs at no cost

UiPath director Bagli Yazdi Framroz received a time-vested RSU award of 34,582 Class A shares under the non-employee director compensation policy.

Rhea-AI Filing Summary

UiPath, Inc. (symbol: PATH) is the issuer of record for a Form 4 filing submitted to the SEC. Bagli Yazdi Framroz reported acquisition or exercise transactions in this Form 4 filing.

UiPath, Inc. (PATH) reported that director Bagli Yazdi Framroz received an equity award of 34,582 shares of Class A Common Stock on September 3, 2026. The award was granted at $0.00 per share under the company’s non-employee director compensation policy and is structured as restricted stock units (RSUs).

These 34,582 RSUs represent a contingent right to receive an equal number of Class A shares upon settlement. One-third of the underlying shares will vest on each of the first, second, and third anniversaries of the grant date, subject to the director’s continued service. Following this grant, the director holds 34,582 shares/RSUs directly.

Insider Trade Summary

Grant/Award: 34,582 shares

Grant/Award 1 txn

Insider Bagli Yazdi Framroz

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock F1, F2	34,582	$0.00	$0.00

Holdings After Transaction: Class A Common Stock — 34,582 shares (Direct)

Footnotes (2)

1. F1. This grant was made pursuant to the issuer's non-employee director compensation policy.
2. F2. Includes 34,582 restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement. One-third of the shares underlying the RSU will vest on each of the first, second, and third anniversaries of the grant, in each case subject to the director's continued service through such vesting date.

Key Figures

RSUs granted: 34,582 shares Transaction price per share: $0.00 per share Shares held after transaction: 34,582 shares +1 more

4 metrics

RSUs granted 34,582 shares Equity award to director on September 3, 2026

Transaction price per share $0.00 per share Grant of RSUs as director compensation

Shares held after transaction 34,582 shares Director’s direct holdings following the RSU grant

Vesting tranches 3 equal installments One-third of RSUs vest on each of the first three anniversaries of grant

Key Terms

restricted stock units (RSUs), non-employee director compensation policy, Class A Common Stock

3 terms

restricted stock units (RSUs) financial

"Includes 34,582 restricted stock units (RSUs). Each RSU represents a contingent right"

Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.

non-employee director compensation policy financial

"This grant was made pursuant to the issuer's non-employee director compensation policy."

Class A Common Stock financial

"Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

FAQ

What insider transaction did UiPath (PATH) disclose for Bagli Yazdi Framroz?

UiPath disclosed that director Bagli Yazdi Framroz received an equity award of 34,582 RSUs representing Class A Common Stock on September 3, 2026, granted at $0.00 per share under the company’s non-employee director compensation policy.

How many UiPath (PATH) shares were granted in this Form 4 filing?

The filing reports a grant of 34,582 restricted stock units (RSUs), each representing a contingent right to receive one share of UiPath’s Class A Common Stock upon settlement, for a total of 34,582 underlying shares if fully vested and settled.

What is the vesting schedule of the 34,582 RSUs reported by UiPath (PATH)?

The 34,582 RSUs vest in three equal installments: one-third of the shares on each of the first, second, and third anniversaries of the grant. Vesting on each date is subject to the director’s continued service through that vesting date.

What is the price per share for the UiPath (PATH) RSU grant to Bagli Yazdi Framroz?

The RSU grant is reported at a transaction price of $0.00 per share, reflecting that it is a compensation award rather than a market purchase. The director did not pay cash consideration for these granted RSUs.

How many UiPath (PATH) shares does Bagli Yazdi Framroz hold after this RSU grant?

After the reported grant, Bagli Yazdi Framroz is shown as directly holding 34,582 shares/RSUs of UiPath Class A Common Stock, corresponding to the full number of RSUs awarded in this transaction, subject to future vesting conditions.

Was the UiPath (PATH) RSU grant made under a Rule 10b5-1 trading plan?

No Rule 10b5-1 trading plan is reported. The filing’s Rule 10b5-1 checkbox is not marked as being made under such a plan, and the footnotes describe the award as granted under the non-employee director compensation policy instead.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/03/2026 - 07:45 PM Accepted by SEC EDGAR 09/03/2026 - 07:44 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bagli Yazdi Framroz

(Last) (First) (Middle)

C/O UIPATH, INC.

ONE VANDERBILT AVENUE, 60TH FLOOR

(Street)

NEW YORK NEW YORK 10017

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
UiPath, Inc. [ PATH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	09/03/2026		A(1)		34,582(2)	A	$0.00	34,582	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This grant was made pursuant to the issuer's non-employee director compensation policy.

2. Includes 34,582 restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement. One-third of the shares underlying the RSU will vest on each of the first, second, and third anniversaries of the grant, in each case subject to the director's continued service through such vesting date.

Remarks:

	/s/ Brad Brubaker, Attorney-in-Fact	09/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)